Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Malnutrition and perspectives of nutritional therapy for mental disorders

https://doi.org/10.14412/2074-2711-2021-2-137-143

Full Text:

Abstract

 Metabolic disorders associated with nutritional  deficiency/imbalance are common in various psychiatric disorders,  including depression, schizophrenia spectrum disorders, dementia,  and eating disorders. Malnutrition degrees vary in a wide range –  from borderline minerals, vitamins, micronutrients deficiency/imbalance to severe metabolic disorders and cachexia.  We present a review of up-to-date publications, meta-analyses, and  systematic reviews on the subject. The need to introduce  supplemental nutrition as an additional component of a therapeutic  strategy for various mental disorders is discussed. The potential of using the products of the Fresubin line is analyzed in detail. 

About the Authors

D. V. Romanov
Department of Psychiatry and Psychosomatic, N.V. Sklifosovsky Clinical Medicine Institute, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia; Department for the Study of Borderline Mental Disease and Psychosomatic Disorders, Mental Health Research Center
Russian Federation

1, Rossolimo St., Build. 1, Moscow 119021, Russia;

34, Kashirskoe Shosse, Moscow 115522, Russia 



K. Yu. Dmitrenko
Department of Psychiatry and Psychosomatic, N.V. Sklifosovsky Clinical Medicine Institute, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation

1, Rossolimo St., Build. 1, Moscow 119021, Russia



References

1. Smulevich AB. Depressii pri psikhicheskikh i somaticheskikh zabolevaniyakh [Depression in mental and somatic diseases]. Moscow: Medical Information Agency; 2015 (In Russ.).

2. Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013;34:119-38. doi: 10.1146/annurevpublhealth-031912-114409

3. Sjöberg L, Karlsson B, Atti AR, et al. Prevalence of depression: Comparisons of different depression definitions in population-based samples of older adults. J Affect Disord. 2017 Oct 15;221:123-31. doi: 10.1016/j.jad.2017.06.011. Epub 2017 Jun 13.

4. Papadimitriou GN, Dikeos DG, Daskalopoulou EG, Soldatos CR. Co-occurrence of disturbed sleep and appetite loss differentiates between unipolar and bipolar depressive episodes. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Oct;26(6):1041-5. doi: 10.1016/s0278-5846(02)00213-0

5. Yoshimura K, Yamada M, Kajiwara Y, et al. Relationship between depression and risk of malnutrition among community-dwelling young-old and old-old elderly people. Aging Mental Health. 2013;17(4):456-60. doi: 10.1080/13607863.2012.743961. Epub 2012 Nov 26.

6. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010 Mar;67(3):220-9. doi: 10.1001/archgenpsychiatry.2010.2

7. Saraswathy KN, Ansari SN, Kaur G, et al. Association of vitamin B 12 mediated hyperhomocysteinemia with depression and anxiety disorder: A cross-sectional study among Bhil indigenous population of India. Clin Nutr ESPEN. 2019 Apr;30:199-203. doi: 10.1016/j.clnesp.2019.01.009. Epub 2019 Feb 12.

8. Bender A, Hagan KE, Kingston N. The association of folate and depression: A meta-analysis. J Psychiatr Res. 2017 Dec;95:9-18. doi: 10.1016/j.jpsychires.2017.07.019. Epub 2017 Jul 22.

9. Moradi F, Lotfi K, Armin M, et al. The association between serum homocysteine and depression: a systematic review and meta-analysis of observational studies. Eur J Clin Invest. 2021 Jan 10;e13486. doi: 10.1111/eci.13486. Online ahead of print.

10. Anglin RES, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Brit J Psychiatry. 2013 Feb;202:100-7. doi: 10.1192/bjp.bp.111.106666

11. Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition. 2016 Mar;32(3):315-20. doi: 10.1016/j.nut.2015.09.003. Epub 2015 Sep 28.

12. Kazemi A, Noorbala AA, Azam K, et al. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial. Clin Nutr. 2019 Apr;38(2):522-8. doi: 10.1016/j.clnu.2018.04.010. Epub 2018 Apr 24.

13. Ng QX, Peters C, Ho CYX, et al. A meta-analysis of the use of probiotics to alleviate depressive symptoms. J Affect Dis. 2018 Mar 1;228:13-9. doi: 10.1016/j.jad.2017.11.063. Epub 2017 Nov 16.

14. Tiganov AS, ed. Psikhiatriya: rukovodstvo dlya vrachey [Psychiatry: A Guide for Physicians]. In 2 vol. Moscow: Meditsina; 2012 (In Russ.).

15. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). Washington – London: American Psychiatric Publishing; 2013.

16. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.

17. Sugawara N, Maruo K, Sugai T, et al. Prevalence of underweight in patients with schizophrenia: A meta-analysis. Schizophr Res. 2018 May;195:67-73. doi: 10.1016/j.schres.2017.10.017. Epub 2017 Oct 17.

18. Onu JU, Osuji PN. Double burden of malnutrition amongst patients with firstepisode schizophrenia in a psychiatric hospital: A 1-year follow-up study. S Afr J Psychiatr. 2020 Nov 10;26:1564. doi: 10.4102/sajpsychiatry.v26i0.1564. eCollection 2020.

19. Firth J, Carney R, Stubbs B, et al. Nutritional deficiencies and clinical correlates in first-episode psychosis: a systematic review and meta-analysis. Schizophr Bull. 2018 Oct 17;44(6):1275-92. doi: 10.1093/schbul/sbx162

20. Valipour G, Saneei P, Esmaillzadeh A. Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies. J Clin Endocrinol Metab. 2014 Oct;99(10):3863-72. doi: 10.1210/jc.2014-1887. Epub 2014 Jul 22.

21. Zhu JL, Luo WW, Cheng X, et al. Vitamin D deficiency and Schizophrenia in adults: a systematic review and meta-analysis of observational studies. Psychiatry Res. 2020 Jun;288:112959. doi: 10.1016/j.psychres.2020.112959. Epub 2020 Apr 18.

22. Solmi M, Pigato GG, Roiter B, et al. Prevalence of catatonia and its moderators in clinical samples: results from a meta-analysis and meta-regression analysis. Schizophr Bull. 2018 Aug 20;44(5):1133-50. doi: 10.1093/schbul/sbx157

23. Grover S, Chakrabarti S, Ghormode D, et al. Catatonia in inpatients with psychiatric disorders: a comparison of schizophrenia and mood disorders. Psychiatry Res. 2015 Oct 30;229(3):919-25. doi: 10.1016/j.psychres.2015.07.020. Epub 2015 Jul 15.

24. Beach SR, Gomez-Bernal F, Huffman JC, Fricchione GL. Alternative treatment strategies for catatonia: A systematic review. Gen Hosp Psychiatry. 2017 Sep;48:1-19. doi: 10.1016/j.genhosppsych.2017.06.011. Epub 2017 Jun 24.

25. Unal A, Altindag A, Demir B, Aksoy I. The Use of Lorazepam and Electroconvulsive Therapy in the Treatment of Catatonia. J ECT. 2017 Dec;33(4):290-3. doi: 10.1097/YCT.0000000000000433

26. Zaman H, Gibson RC, Walcott G. Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses. Cochrane Database Syst Rev. 2019 Aug 5;8(8):CD006570. doi: 10.1002/14651858.CD006570.pub3

27. Berry N, Sagar R, Tripathi BM. Catatonia and other psychiatric symptoms with vitamin B 12 deficiency. Acta Psychiatr Scand. 2003 Aug;108(2):156-9. doi: 10.1034/j.1600-0447.2003.00089.x

28. Catalano G, Catalano MC, Rosenberg EI, et al. Catatonia: another neuropsychiatric presentation of vitamin B12 deficiency? Psychosomatics. Sep-Oct 1998;39(5):456-60. doi: 10.1016/S0033-3182(98)71307-6

29. Bram D, Bubrovszky M, Durand J-P, et al. Pernicious anemia presenting as catatonia: correlating vitamin B12 levels and catatonic symptoms. Gen Hosp Psychiatry. May-Jun 2015;37(3):273.e5-7. doi: 10.1016/j.genhosppsych.2015.02.003. Epub 2015 Feb 23.

30. Brunoni AR, Nakata ACG, Tung TC, Busatto GF. Vitamin D-Resistant Rickets Type II-A, Basal Ganglia Calcification, and Catatonia: A Casual or Causal Relationship? Psychosomatics. 2009;50(4):420-4. doi: 10.1176/appi.psy.50.4.420

31. Suman A, Shouan A, Grover S. Catatonia in a young woman with intellectual disability and vitamin D deficiency managed with electroconvulsive therapy. J Mental Health Hum Behav. 2020;25(1):60.

32. Levenson JL, Pandurangi AK. Prognosis and complications. Catatonia: From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Publishing; 2004. P. 161-72.

33. Keski-Rahkonen A, Hoek HW, Susser ES, et al. Epidemiology and course of anorexia nervosa in the community. Am J Psychiatry. 2007 Aug;164(8):1259-65. doi: 10.1176/appi.ajp.2007.06081388

34. Wade TD, Bergin JL, Tiggemann M, et al. Prevalence and long-term course of lifetime eating disorders in an adult Australian twin cohort. Aust N Z J Psychiatry. 2006 Feb;40(2):121-8. doi: 10.1080/j.1440-1614.2006.01758.x

35. Bulik CM, Sullivan PF, Tozzi F, et al. Prevalence, heritability, and prospective risk factors for anorexia nervosa. Arch Gen Psychiatry. 2006 Mar;63(3):305-12. doi: 10.1001/archpsyc.63.3.305

36. Keel PK, Heatherton TF, Dorer DJ, et al. Point prevalence of bulimia nervosa in 1982, 1992, and 2002. Psychol Med. 2006 Jan;36(1):119-27. doi: 10.1017/S0033291705006148. Epub 2005 Oct 5.

37. Hudson JI, Hiripi E, Pope Jr HG, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 Feb 1;61(3):348-58. doi: 10.1016/j.biopsych.2006.03.040. Epub 2006 Jul 3.

38. Preti A, de Girolamo G, Vilagut G, et al; ESEMeD-WMH Investigators. The epidemiology of eating disorders in six European countries: results of the ESEMeD-WMH project. J Psychiatr Res. 2009 Sep;43(14):1125-32. doi: 10.1016/j.jpsychires.2009.04.003. Epub 2009 May 8.

39. Swanson SA, Crow SJ, Le Grange D, et al. Prevalence and correlates of eating disorders in adolescents: Results from the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry. 2011 Jul;68(7):714-23. doi: 10.1001/archgenpsychiatry.2011.22. Epub 2011 Mar 7.

40. Marques L, Alegria M, Becker AE, et al. Comparative prevalence, correlates of impairment, and service utilization for eating disorders across US ethnic groups: Implications for reducing ethnic disparities in health care access for eating disorders. Int J Eating Disord. 2011 Jul;44(5):412-20. doi: 10.1002/eat.20787. Epub 2010 Jul 27.

41. Trace SE, Thornton LM, Root TL, et al. Effects of reducing the frequency and duration criteria for binge eating on lifetime prevalence of bulimia nervosa and binge eating disorder: Implications for DSM-5. Int J Eating Disord. 2012 May;45(4):531-6. doi: 10.1002/eat.20955. Epub 2011 Aug 31.

42. Crowther JH, Armey M, Luce KH, et al. The point prevalence of bulimic disorders from 1990 to 2004. Int J Eating Disord. 2008 Sep;41(6):491-7. doi: 10.1002/eat.20537

43. Qian J, Hu Q, Wan Y, et al. Prevalence of eating disorders in the general population: a systematic review. Shanghai Arch Psychiatry. 2013 Aug;25(4):212-23. doi: 10.3969/j.issn.1002-0829.2013.04.003

44. Hanachi M, Dicembre M, Rives-Lange C, et al. Micronutrients deficiencies in 374 severely malnourished anorexia nervosa inpatients. Nutrients. 2019 Apr 5;11(4):792. doi: 10.3390/nu11040792

45. Franques J, Chiche L, Mathis S. Sensory neuronopathy revealing severe vitamin B12 deficiency in a patient with anorexia nervosa: an often-forgotten reversible cause. Nutrients. 2017 Mar 15;9(3):281. doi: 10.3390/nu9030281

46. Suzuki H, Asakawa A, Li JB, et al. Zinc as an appetite stimulator-the possible role of zinc in the progression of diseases such as cachexia and sarcopenia. Recent Pat Food Nutr Agric. 2011 Sep;3(3):226-31. doi: 10.2174/2212798411103030226

47. Birmingham CL, Goldner EM, Bakan R. Controlled trial of zinc supplementation in anorexia nervosa. Int J Eat Disord. 1994;15:251-5.

48. Gatti D, El Ghoch M, Viapiana O, et al. Strong relationship between vitamin D status and bone mineral density in anorexia nervosa. Bone. 2015 Sep;78:212-5. doi: 10.1016/j.bone.2015.05.014. Epub 2015 May 14.

49. Diaz-Marsa M, Alberdi-Paramo I, Niell-Galmes L. Suplementos nutricionales en trastornos de la conducta alimentaria. Actas Esp Psiquiatr. 2017 Sep;45(Suppl):26-36. Epub 2017 Sep 1.

50. Garber AK, Sawyer SM, Golden NH, et al. A systematic review of approaches to refeeding in patients with anorexia nervosa. Int J Eating Disord. 2016 Mar;49(3):293-310. doi: 10.1002/eat.22482. Epub 2015 Dec 12.

51. Mattar L, Godart N, Melchior JC, Pichard C. Anorexia nervosa and nutritional assessment: contribution of body composition measurements. Nutr Res Rev. 2011 Jun;24(1):39-45. doi: 10.1017/S0954422410000284.Epub 2011 Mar 8.

52. Rizzo SM, Douglas JW, Lawrence JC. Enteral nutrition via nasogastric tube for refeeding patients with anorexia nervosa: a systematic review. Nutr Clin Pract. 2019 Jun;34(3):359-70. doi: 10.1002/ncp.10187. Epub 2018 Aug 2.

53. Prince M, Bryce R, Albanese E, et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013 Jan;9(1):63-75.e2. doi: 10.1016/j.jalz.2012.11.007

54. Fiest KM, Jette N, Roberts JI, et al. The prevalence and incidence of dementia: a systematic review and meta-analysis. Canad J Neurol Sci. 2016 Apr;43 Suppl 1:S3-S50. doi: 10.1017/cjn.2016.18

55. Favaro-Moreira NC, Krausch-Hofmann S, Matthys C, et al. Risk factors for malnutrition in older adults: a systematic review of the literature based on longitudinal data. Adv Nutr. 2016 May 16;7(3):507-22. doi: 10.3945/an.115.011254. Print 2016 May.

56. Volkert D, Chourdakis M, Faxen-Irving G, et al. ESPEN guidelines on nutrition in dementia. Clin Nutr. 2015 Dec;34(6):1052- 73. doi: 10.1016/j.clnu.2015.09.004. Epub 2015 Sep 25.

57. Roque M, Salva A, Vellas B. Malnutrition in community-dwelling adults with dementia (NutriAlz Trial). J Nutrit Health Aging. 2013 Apr;17(4):295-9. doi: 10.1007/s12603-012-0401-9

58. Yildiz D, Pekel NB, Kilic AK, et al. Malnutrition is associated with dementia severity and geriatricsyndromes in patients with Alzheimer disease. Turk J Med Sci. 2015;45(5):1078-81. doi: 10.3906/sag-1406-76

59. Kimura A, Sugimoto T, Kitamori K, et al. Malnutrition is associated with behavioral and psychiatric symptoms of dementia in older women with mild cognitive impairment and early-stage Alzheimer's disease. Nutrients. 2019 Aug 20;11(8):1951. doi: 10.3390/nu11081951

60. Minaglia C, Giannotti C, Boccardi V, et al. Cachexia and advanced dementia. J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):263-77. doi: 10.1002/jcsm.12380. Epub 2019 Feb 22.

61. Norman K, Kirchner H, Freudenreich M, et al. Three month intervention with protein and energy rich supplements improve muscle function and quality of life in malnourished patients with non-neoplastic gastrointestinal disease – A randomized controlled trial. Clin Nutr. 2008 Feb;27(1):48-56. doi: 10.1016/j.clnu.2007.08.011. Epub 2007 Oct 25.

62. McMurdo MET, Price RJG, Shields M, et al. Should Oral Nutritional Supplementation Be Given to Undernourished Older People upon Hospital Discharge? A Controlled Trial. J Am Geriatr Soc. 2009 Dec;57(12):2239-45. doi: 10.1111/j.1532-5415.2009.02568.x. Epub 2009 Nov 17.

63. Cawood AL, Elia M, Stratton RJ. Systematic review and meta-analysis of the effects of high protein oral nutritional supplements. Ageing Res Rev. 2012 Apr;11(2):278-96. doi: 10.1016/j.arr.2011.12.008. Epub 2011 Dec 22.

64. Stratton RJ, Hebuterne X, Elia M. A systematic review and meta-analysis of the impact of oral nutritional supplements on hospital readmissions. Ageing Res Rev. 2013 Sep;12(4):884-97. doi: 10.1016/j.arr.2013.07.002. Epub 2013 Jul 24.

65. Born C, de la Fontaine L. P02-117 – Preliminary retrospective analysis of a refeeding program in a psychiatric intensive care unit for patients suffering from extreme severe anorexia nervosa. Eur Psychiatry. 2011;26:713. doi: 10.1016/s0924-9338(11)72418-x


For citation:


Romanov D.V., Dmitrenko K.Yu. Malnutrition and perspectives of nutritional therapy for mental disorders. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(2):137-143. (In Russ.) https://doi.org/10.14412/2074-2711-2021-2-137-143

Views: 37


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)